The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis

JF Swart; D. Barug; M. Möhlmann; N.M. Wulffraat

The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis

Translated title of the contribution: The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis

JF Swart, D. Barug, M. Möhlmann, N.M. Wulffraat

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
Original language	Undefined/Unknown
Pages (from-to)	1743-1752
Number of pages	10
Journal	Expert Opinion on Biological Therapy
Volume	10
Issue number	12
Publication status	Published - 2010

Cite this

@article{6cbe842f45a84caa8a78c44879b36b8e,

title = "The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis",

author = "JF Swart and D. Barug and M. M{\"o}hlmann and N.M. Wulffraat",

year = "2010",

language = "Undefined/Unknown",

volume = "10",

pages = "1743--1752",

journal = "Expert Opinion on Biological Therapy",

issn = "1471-2598",

publisher = "Informa Healthcare",

number = "12",

}

TY - JOUR

T1 - The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis

AU - Swart, JF

AU - Barug, D.

AU - Möhlmann, M.

AU - Wulffraat, N.M.

PY - 2010

Y1 - 2010

M3 - Article

SN - 1471-2598

VL - 10

SP - 1743

EP - 1752

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

IS - 12

ER -